Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 09:02 am Purchase |
2023-12-31 | 13G | BioCryst Pharmaceuticals, Inc. BCRX |
Avoro Capital Advisors LLC | 13,050,000 6.400% |
13,050,000 (New Position) |
Filing History |
| 2024-02-14 09:00 am Sale |
2023-12-31 | 13G | IO Biotech, Inc. IOBT |
Avoro Capital Advisors LLC | 0 0.000% |
-2,055,883 (Position Closed) |
Filing History |
| 2023-02-14 09:41 am Sale |
2022-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE |
Avoro Capital Advisors LLC | 4,900,000 7.800% |
-85,000 (-1.71%) |
Filing History |
| 2023-02-14 09:40 am Purchase |
2022-12-31 | 13G | Monte Rosa Therapeutics, Inc. GLUE |
Avoro Capital Advisors LLC | 4,325,000 8.900% |
1,013,566 (+30.61%) |
Filing History |
| 2023-02-14 09:38 am Purchase |
2022-12-31 | 13G | Mersana Therapeutics, Inc. MRSN |
Avoro Capital Advisors LLC | 7,550,000 7.600% |
750,000 (+11.03%) |
Filing History |
| 2023-02-14 09:37 am Sale |
2022-12-31 | 13G | IVERIC bio, Inc. ISEE |
Avoro Capital Advisors LLC | 6,750,000 4.960% |
-500,000 (-6.90%) |
Filing History |
| 2023-02-14 09:37 am Purchase |
2022-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
Avoro Capital Advisors LLC | 1,660,000 9.700% |
235,000 (+16.49%) |
Filing History |
| 2023-02-14 09:37 am Purchase |
2022-12-31 | 13G | Kymera Therapeutics, Inc. KYMR |
Avoro Capital Advisors LLC | 3,850,000 7.000% |
3,850,000 (New Position) |
Filing History |
| 2023-02-14 09:36 am Purchase |
2022-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
Avoro Capital Advisors LLC | 10,625,000 9.600% |
2,069,445 (+24.19%) |
Filing History |
| 2023-02-14 09:36 am Sale |
2022-12-31 | 13G | Marinus Pharmaceuticals, Inc. MRNS |
Avoro Capital Advisors LLC | 3,150,000 6.300% |
-85,000 (-2.63%) |
Filing History |
| 2023-02-14 09:35 am Purchase |
2022-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
Avoro Capital Advisors LLC | 26,800,000 9.500% |
8,300,000 (+44.86%) |
Filing History |
| 2023-02-14 09:35 am Purchase |
2022-12-31 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Avoro Capital Advisors LLC | 3,060,000 6.700% |
1,595,000 (+108.87%) |
Filing History |
| 2023-02-14 09:34 am Sale |
2022-12-31 | 13G | United Therapeutics Corporation UTHR |
Avoro Capital Advisors LLC | 2,865,000 6.300% |
-170,000 (-5.60%) |
Filing History |
| 2023-02-14 09:34 am Purchase |
2022-12-31 | 13G | Mirati Therapeutics, Inc. MRTX |
Avoro Capital Advisors LLC | 5,555,555 9.600% |
480,555 (+9.47%) |
Filing History |
| 2023-02-14 09:33 am Purchase |
2022-12-31 | 13G | Krystal Biotech, Inc. KRYS |
Avoro Capital Advisors LLC | 1,410,000 5.500% |
1,410,000 (New Position) |
Filing History |
| 2023-02-14 09:33 am Purchase |
2022-12-31 | 13G | Ascendis Pharma A/S ASND |
Avoro Capital Advisors LLC | 3,100,000 5.400% |
3,100,000 (New Position) |
Filing History |
| 2023-02-14 09:32 am Sale |
2022-12-31 | 13G | Kura Oncology, Inc. KURA |
Avoro Capital Advisors LLC | 3,105,000 4.500% |
-895,000 (-22.38%) |
Filing History |
| 2023-02-14 09:32 am Purchase |
2022-12-31 | 13G | DICE Therapeutics, Inc. DICE |
Avoro Capital Advisors LLC | 2,525,555 5.300% |
2,525,555 (New Position) |
Filing History |
| 2023-02-14 09:31 am Sale |
2022-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA |
Avoro Capital Advisors LLC | 7,020,000 4.400% |
-1,655,000 (-19.08%) |
Filing History |
| 2023-02-14 09:30 am Sale |
2022-12-31 | 13G | Adverum Biotechnologies, Inc. ADVM |
Avoro Capital Advisors LLC | 0 0.000% |
-695,000 (Position Closed) |
Filing History |